The American Society of Clinical Oncology and Association of Community Cancer Centers are working to foster participation in cancer treatment trials to more fully reflect the diversity of people at risk for or living with cancer.
In 1999, Richard Pazdur, a GI oncologist at MD Anderson, saw an FDA recruitment ad in The New England Journal of Medicine. The agency was looking for a director of the FDA Division of Oncology Drug Products.
